Related references
Note: Only part of the references are listed.Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro Mikael da Silva Costa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)
Transcriptome analysis of newly established carboplatin-resistant ovarian cancer cell model reveals genes shared by drug resistance and drug-induced EMT
Juran Kralj et al.
BRITISH JOURNAL OF CANCER (2023)
Mutational drivers of cancer cell migration and invasion
Nikita M. Novikov et al.
BRITISH JOURNAL OF CANCER (2021)
Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing
Aleksandra Majchrzak-Celinska et al.
GENES (2021)
EMT-associated microRNAs and their roles in cancer stemness and drug resistance
Guangtao Pan et al.
CANCER COMMUNICATIONS (2021)
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview
Riccardo Di Fiore et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pancancer survival analysis of cancer hallmark genes
Adam Nagy et al.
SCIENTIFIC REPORTS (2021)
Ovarian cancer: epigenetics, drug resistance, and progression
Weiwei Xie et al.
CANCER CELL INTERNATIONAL (2021)
Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies
Narendra Wajapeyee et al.
CANCER RESEARCH (2021)
The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes
Tasnim H. Beacon et al.
CLINICAL EPIGENETICS (2021)
The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness
Yuxi Ma et al.
CELLS (2021)
Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets
K. M. Taufiqul Arif et al.
CANCERS (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1
G. Zhang et al.
NEOPLASMA (2020)
MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma
Guizhi Zhao et al.
BIOLOGICAL RESEARCH (2020)
MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer
Zhenghui Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
Angiolo Gadducci et al.
JOURNAL OF OVARIAN RESEARCH (2019)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis
Jordi Pijuan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
The roles of microRNAs in epigenetic regulation
Qian Yao et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer
Sanna Khan et al.
BIOCHIMIE (2019)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
Takeshi Motohara et al.
ONCOGENE (2019)
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis
Vitaly I. Loginov et al.
GENE (2018)
Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways
Kangmei Chen et al.
THERANOSTICS (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The relationship between platinum drug resistance and epithelial-mesenchymal transition
Anamaria Brozovic
ARCHIVES OF TOXICOLOGY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network
Kecheng Zhou et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2017)
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
George E. Duran et al.
BRITISH JOURNAL OF CANCER (2017)
DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers
Ching-Yu Yen et al.
CANCER LETTERS (2016)
被撤回的出版物: MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer (Retracted article. See vol. 59, 2021)
Huan Xia et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Regulatory mechanisms of microRNA expression
Lyudmila F. Gulyaeva et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression
Esther Castellano et al.
NATURE COMMUNICATIONS (2016)
The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
Anamaria Brozovic et al.
MOLECULAR ONCOLOGY (2015)
Role of ErbB Receptors in Cancer Cell Migration and Invasion
Aline Appert-Collin et al.
FRONTIERS IN PHARMACOLOGY (2015)
Transfection of microRNA Mimics Should Be Used with Caution
Hyun Yong Jin et al.
FRONTIERS IN GENETICS (2015)
Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
H. Yang et al.
BRITISH JOURNAL OF CANCER (2015)
Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
Francois Moisan et al.
MOLECULAR ONCOLOGY (2014)
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
E. Mogilyansky et al.
CELL DEATH AND DIFFERENTIATION (2013)
Regulation of microRNAs by epigenetics and their interplay involved in cancer
Xiaolan Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
ENCODE Data in the UCSC Genome Browser: year 5 update
Kate R. Rosenbloom et al.
NUCLEIC ACIDS RESEARCH (2013)
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
Michael S. Anglesio et al.
PLoS One (2013)
MicroRNAs Micromanage Themselves
Alan Jiao et al.
CIRCULATION RESEARCH (2012)
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
V. Davalos et al.
ONCOGENE (2012)
Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network
Jin Wang et al.
BMC SYSTEMS BIOLOGY (2011)
Recent Progress in the Diagnosis and Treatment of Ovarian Cancer
Danijela Jelovac et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of MicroRNA Genes in Colorectal Cancer
Hiromu Suzuki et al.
CANCER RESEARCH (2011)
Epigenetic regulation of microRNAs in cancer: An integrated review of literature
Tanja Kunej et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
N. Ahmed et al.
CURRENT CANCER DRUG TARGETS (2010)
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer
Kwang-Hyuck Lee et al.
PANCREATOLOGY (2009)
Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines
Yoshinao Ruike et al.
JOURNAL OF HUMAN GENETICS (2008)
Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally
Yu Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2007)
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists
Da Wei Huang et al.
GENOME BIOLOGY (2007)
The UCSC Table Browser data retrieval tool
D Karolchik et al.
NUCLEIC ACIDS RESEARCH (2004)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer
Y Watanabe et al.
BRITISH JOURNAL OF CANCER (2001)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
